Bethesda, MD., February 18, 2014 – The Parenteral Drug Association (PDA) is proud to announce that Dr. Mark B. McClellan, Director, Health Care Innovation and Value Initiative for the Brookings Institute and former FDA Commissioner and Dr. Rahul Singhvi, Chief Operating Officer, Vaccines, Takeda Pharmaceuticals International will be the Opening Plenary Speakers at the 2014 PDA Annual Meeting, April 7-9, JW Marriott San Antonio Hilly Country Resort & Spa in San Antonio, Texas.
Dr. McClellan’s work focuses on promoting quality and value in patient centered health care. As doctor and economist by training, he also has a highly distinguished record in public service and in academic research.
Dr. Singhvi has held several key positions in R&D and manufacturing with increasing responsibilities in the vaccine development process, including co-lead of the varicella-zoster virus vaccine project team that oversaw the development of Varivax®III (chickenpox vaccine), and Zostavax® (Shingles vaccine).
The 2014 PDA Annual Meeting will address the rapid changes in pharmaceutical manufacturing technologies that are occurring in response to new regulations, requirements and capabilities. This year’s theme is Biopharmaceutical and Sterile Manufacturing – Embracing Innovation to Meeting Global Challenges. It will include educational opportunities in the areas of biological sciences, product manufacturing and quality systems, which include over 60 presentations and case studies led by industry and regulatory leaders.
For more information, visit http://pdaannualmeeting.org. Press inquiries about registration should be directed to Richard Johnson, email@example.com.